Keywords: Tumors (Pre-Treatment), DSC & DCE Perfusion, Telomerase reverse transcriptase
Motivation: This study aims to predict the TERTp mutation status noninvasively before surgery, which is crucial for determining treatment strategies and prognosis in GBM patients.
Goal(s): Investigate the predictive value of DCE-MRI and IVIM for TERTp mutation status in GBM patients.
Approach: 68 GBM patients were enrolled according to the 2021 WHO classification, and divided into TERTp mutant group and TERTp wild group. Compare DCE-MRI and IVIM parameters between the two groups.
Results: The DCE-MRI parameter Vp was significantly higher in the TERTp mutation group (AUC=0.708), indicating its potential as a predictor for TERTp mutation status.
Impact: This study suggests that Vp, a DCE-MRI parameter, can predict TERTp mutation status noninvasively. This has important implications for targeted therapy and prognosis prediction in GBM patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords